News

FDA's New Drug Safety Board Under Scrutiny : Critics say board may lack independence and authority and may not have sufficient resources.


 

For more information about the new FDA oversight initiative, seehttp://www.fda.gov/cder/drugsafety.htm

Pages

Recommended Reading

Policy & Practice
MDedge Neurology
Council Crafts Plan to Accredit Subspecialties
MDedge Neurology
Policy & Practice
MDedge Neurology